to experience the full functionality of mail.com.
Enhanced by Google
September 26, 2016
Drugmaker Pfizer decides not to break up business
Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its ...
August 22, 2016
Pfizer spends $14B on Medivation in cancer fight
Pfizer will pay about $14 billion to buy cancer drug developer Medivation in a cash deal aimed at fortifying its hold in one ...
August 02, 2016
Pfizer beats Street 2Q forecasts despite big drop in profit
Rising sales of Pfizer Inc.'s key new medicines and prospects that more drugs will be approved soon have analysts speculating ...
May 16, 2016
Pfizer buying skin drug maker Anacor for $5.2 billion
Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin disorder treatments ...
May 10, 2016
Allergan plans to buy back $10B in shares, posts 1Q profit
Allergan will buy back up to $10 billion in stock following a swing to a first-quarter profit on a strong surge in sales of ...
May 03, 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes
Pfizer easily beat Wall Street expectations as the biggest U.S. drugmaker's first-quarter net income jumped 27 percent due ...
April 28, 2016
Shareholders criticize Pfizer after scrapped Allergan deal
Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to ...